RARITAN, N.J., Dec. 30 (HSMN NewsFeed) — Johnson & Johnson Pharma Research & Development, L.L.C. (J&JPRD) today announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Appl…
Biopharmaceuticals, FDA
J&JPRD, ceftobiprole, cSSSI, Basilea Pharmaceutica

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “FDA Issues Complete Response Letter for Ceftobiprole”
Leave a Comment